HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Otten Selected Research

Paleolithic Diet

9/2021The liver-alpha-cell axis after a mixed meal and during weight loss in type 2 diabetes.
3/2021Using a Paleo Ratio to Assess Adherence to Paleolithic Dietary Recommendations in a Randomized Controlled Trial of Individuals with Type 2 Diabetes.
6/2019Postprandial levels of GLP-1, GIP and glucagon after 2 years of weight loss with a Paleolithic diet: a randomised controlled trial in healthy obese women.
1/2019Exercise Training Adds Cardiometabolic Benefits of a Paleolithic Diet in Type 2 Diabetes Mellitus.
1/2018A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial.
1/2017A Paleolithic Diet with and without Combined Aerobic and Resistance Exercise Increases Functional Brain Responses and Hippocampal Volume in Subjects with Type 2 Diabetes.
1/2017Benefits of a Paleolithic diet with and without supervised exercise on fat mass, insulin sensitivity, and glycemic control: a randomized controlled trial in individuals with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Otten Research Topics

Disease

9Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2017
7Insulin Resistance
01/2022 - 09/2014
5Weight Loss (Weight Reduction)
09/2021 - 01/2017
1Glucose Intolerance
01/2022
1Diabetes Complications
01/2022
1Neoplasms (Cancer)
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Obesity
04/2020
1Ventricular Remodeling
01/2019
1Overweight
01/2019
1Cardiomegaly (Heart Hypertrophy)
03/2010
1Cardiomyopathies (Cardiomyopathy)
03/2010

Drug/Important Bio-Agent (IBA)

5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2014
2Proteins (Proteins, Gene)FDA Link
09/2021 - 03/2010
2Glucagon (Glukagon)FDA Link
09/2021 - 06/2019
2Triglycerides (Triacylglycerol)IBA
03/2021 - 01/2019
2Metformin (Glucophage)FDA LinkGeneric
04/2020 - 01/2017
1Blood Glucose (Blood Sugar)IBA
01/2022
1C-PeptideIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1CholesterolIBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
03/2021
1LipidsIBA
03/2021
1Hydrocortisone (Cortisol)FDA LinkGeneric
04/2020
1CortisoneFDA Link
04/2020
1GlucocorticoidsIBA
04/2020
1Peptides (Polypeptides)IBA
06/2019
1Glucagon-Like Peptide 1 (GLP 1)IBA
06/2019
1Protons (Proton)IBA
01/2018
1LeptinIBA
01/2017
1Oxygen (Dioxygen)IBA
01/2017
1F-actin-binding proteinsIBA
03/2010
1Protein Isoforms (Isoforms)IBA
03/2010

Therapy/Procedure

7Paleolithic Diet
09/2021 - 01/2017
1Glycemic Control
01/2017